Article
The Impact of EGFR Tyrosine Kinase Inhibitor on the Natural Course of Concurrent Subsolid Nodules in Patients with Non-Small Cell Lung Cancer.
Cancer research and treatment - 1 Jul 2022
Kang Noeul, Kim Ki Hwan, Jeong Byeong-Ho, Lee Kyungjong, Kim Hojoong, Kwon O Jung, Ahn Myung-Ju, Cho Jeonghee, Lee Ho Yun, Um Sang-Won
Abstract excerpt
PURPOSE: The role of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in the management of persistent subsolid nodules (SSNs) is unclear. This study aimed to investigate the impact of EGFR-TKIs on concurrent SSNs in patients with stage IV non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Patients who received an EGFR-TKI for at least 1 month for stage IV NSCLC and had concurrent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
